Xofluza (baloxavir marboxil)

£177.00£409.00

Xofluza (baloxavir marboxil) is indicated for the treatment acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours.

This medicine is not (yet) part of our standard product range but we may be able to get it for you. The packaging size and strength below may vary due to product availability. Please contact us to verify price and availability.

DISEASE INDICATIONS

Influenza

MANUFACTURER

Genentech, Inc

USAGE

Oral

MEDICINE APPROVED BY

  • European Medical Agency (EMA)

  • Food and Drug Administration (FDA)

    PATIENTS HELPED

    • Over 1.2 million patients reached

    • More than 11,000 patients helped

    • 100% successful deliveries to 88 countries

    WE CAN HELP WITH YOUR IMPORT DOCUMENTS

This content has been reviewed by a Medical Doctor.
XOFLUZA (BALOXAVIR MARBOXIL)-1 Package

2 tablets of 20 mg, 4 tablets of 20 mg, 1 tablet of 40 mg, 2 tablets of 40 mg

Reviews

There are no reviews yet.

Be the first to review “Xofluza (baloxavir marboxil)”

Your email address will not be published. Required fields are marked *

Shopping Cart